Effect of diet on lipid profile in HIV-infected patients

被引:2
|
作者
Jackiewicz, Agata [1 ]
Czarnecki, Marcin [1 ]
Knysz, Brygida [1 ]
机构
[1] Wroclaw Med Univ, Dept Infect Dis Liver Dis & Acquired Immune Defic, 5 Koszarowa St, PL-51171 Wroclaw, Poland
来源
HIV & AIDS REVIEW | 2018年 / 17卷 / 03期
关键词
HIV; cardiovascular risk; lipid profile; diet therapy; antiretroviral therapy;
D O I
10.5114/hivar.2018.78484
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The implementation of highly active antiretroviral therapy has increased the life expectancy of people living with human immunodeficiency virus (HIV), thus reducing the number of deaths from acquired immune deficiency syndrome. Nowadays life expectancy of HIV(+) patients is comparable to those who are not infected. However, due to the use of antiretroviral therapy and the persistent immune activation and inflammation caused by HIV, other negative events may occur including dyslipidaemias, cardiovascular disorders, chronic kidney disease, early ageing, and neurocognitive impairment. It also increases the risk of developing metabolic syndrome and becomes a risk factor for cardiovascular disease: e.g. hypertension, brain stroke, and heart infarct. Comprehensive care of HIV patients with disturbed lipid profile includes lifestyle modifications such as dietary changes along with smoking cessation and has a beneficial effect on the lipid profile (total cholesterol, LDL, HDL, triglyceride levels). Therefore, it can reduce the risk of cardiovascular disease, allows the patients to avoid additional pharmacotherapy, and can eliminate drug-drug interactions with antiretroviral drugs. There are a lot of data showing that early dietary intervention and consistent diet control have a beneficial effect on lipid disorders in HIV-infected patients. Clinicians should be aware of it. In view of the benefits that can be gained by people living with HIV from dietary intervention, it is appropriate to include dieticians in a panel of specialists who take care of HIV(+) patients.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [31] Effect of daily consumption of extra virgin olive oil on the lipid profile and microbiota of HIV-infected patients over 50 years of age
    Olalla, Julian
    Garcia de Lomas, Jose M.
    Chueca, Natalia
    Perez-Stachowski, Xavier
    De Salazar, Adolfo
    Del Arco, Alfonso
    Plaza-Diaz, Julio
    De la Torre, Javier
    Luis Prada, Jose
    Garcia-Alegria, Javier
    Fernandez-Sanchez, Fernando
    Garcia, Federico
    MEDICINE, 2019, 98 (42) : e17528
  • [32] The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy
    Shah, M
    Tierney, K
    Adams-Huet, B
    Boonyavarakul, A
    Jacob, K
    Quittner, C
    Dinges, WL
    Peterson, D
    Garg, A
    HIV MEDICINE, 2005, 6 (04) : 291 - 298
  • [33] Effects of an indinavir/ritonavir-based dual protease inhibitor regimen on the lipid profile of HIV-infected patients
    Wilson, H
    Rawlins, S
    Ma, L
    Petruschke, R
    Abramson, M
    ANTIVIRAL THERAPY, 2003, 8 (04) : L49 - L50
  • [34] Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
    Magenta, L.
    Dell-Kuster, S.
    Richter, W. O.
    Young, J.
    Hasse, B.
    Flepp, M.
    Hirschel, B.
    Vernazza, P.
    Evison, J.
    Cavassini, M.
    Decosterd, L. A.
    Bucher, H. C.
    Bernasconi, E.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (05) : 525 - 533
  • [35] Alteration in Lipid Profile in Treatment-Naive HIV-Infected Patients and Changes Following HAART Initiation in Haryana
    Singh, Jagjeet
    Verma, Monica
    Ghalaut, Pratap Singh
    Verma, Renuka
    Soni, Abhishek
    Ghalaut, Veena Singh
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2014, 4 (1-2) : 25 - 31
  • [36] THE EFFECT OF ACETAMINOPHEN ON ZIDOVUDINE METABOLISM IN HIV-INFECTED PATIENTS
    STEFFE, EM
    KING, JH
    INCIARDI, JF
    FLYNN, NF
    GOLDSTEIN, E
    TONJES, TS
    BENET, LZ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (07): : 691 - 694
  • [37] Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
    Sriwiriyajan, Somchai
    Mahatthanatrakul, Werawath
    Ridtitid, Wibool
    Jaruratanasirikul, Sutep
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 479 - 483
  • [38] Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
    Somchai Sriwiriyajan
    Werawath Mahatthanatrakul
    Wibool Ridtitid
    Sutep Jaruratanasirikul
    European Journal of Clinical Pharmacology, 2007, 63 : 479 - 483
  • [39] Effect of Antiretroviral class on hepatotoxicity in HIV-infected patients
    Ritchey, Mary E.
    Laurent, Samantha A. St.
    Russo, Mark W.
    Jonsson-Funk, Michele L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S209 - S209
  • [40] Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations
    Torti, C
    Quiros-Roldan, E
    Regazzi-Bonora, M
    De Luca, A
    Lo Caputo, S
    Di Giambenedetto, S
    Patroni, A
    Villani, P
    Micheli, V
    Carosi, G
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (03) : 324 - 326